Literature DB >> 9878397

Inducible site-specific recombination in the brain.

C Kellendonk1, F Tronche, E Casanova, K Anlag, C Opherk, G Schütz.   

Abstract

The Cre/loxP recombination system allows the generation of tissue-specific somatic mutations in mice. Additional temporal control of somatic mutagenesis is highly desirable, as this would permit a more precise analysis of gene function in complex systems such as the central nervous system. Extending our previous studies, we compared several ligand-regulated recombinases, in which the ligand-binding domain (LBD) of the progesterone receptor or the estrogen receptor was fused to the Cre recombinase. A fusion protein between the Cre recombinase and a truncated LBD of the progesterone receptor was chosen to obtain inducible recombination in the brain. This fusion protein can be activated by the synthetic steroid RU486, but not by the physiological hormone progesterone. Its expression was targeted to the brain using regulatory sequences of the calcium-calmodulin-dependent kinase IIalpha or the Thy-1 gene. Application of RU486 to the mice induced Cre-mediated recombination of a lacZ reporter transgene in the cortex and hippocampus, showing that spatially and temporally controlled gene targeting can be mediated in the brain. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9878397     DOI: 10.1006/jmbi.1998.2307

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  44 in total

1.  Cerebellar granule cell-specific and inducible expression of Cre recombinase in the mouse.

Authors:  M Tsujita; H Mori; M Watanabe; M Suzuki; J Miyazaki; M Mishina
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

2.  Stringent doxycycline dependent control of CRE recombinase in vivo.

Authors:  Kai Schönig; Frieder Schwenk; Klaus Rajewsky; Hermann Bujard
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

3.  New variants of inducible Cre recombinase: a novel mutant of Cre-PR fusion protein exhibits enhanced sensitivity and an expanded range of inducibility.

Authors:  F T Wunderlich; H Wildner; K Rajewsky; F Edenhofer
Journal:  Nucleic Acids Res       Date:  2001-05-15       Impact factor: 16.971

Review 4.  Genetic targeting of cerebellar Purkinje cells: history, current status and novel strategies.

Authors:  Jaroslaw J Barski; Matthias Lauth; Michael Meyer
Journal:  Cerebellum       Date:  2002-04       Impact factor: 3.847

Review 5.  Conditional gene expression in the mouse inner ear using Cre-loxP.

Authors:  Brandon C Cox; Zhiyong Liu; Marcia M Mellado Lagarde; Jian Zuo
Journal:  J Assoc Res Otolaryngol       Date:  2012-04-24

Review 6.  Molecular neuroanatomy's "Three Gs": a primer.

Authors:  Susan M Dymecki; Jun Chul Kim
Journal:  Neuron       Date:  2007-04-05       Impact factor: 17.173

Review 7.  Adopting the good reFLEXes when generating conditional alterations in the mouse genome.

Authors:  Frank Schnütgen; Norbert B Ghyselinck
Journal:  Transgenic Res       Date:  2007-04-06       Impact factor: 2.788

Review 8.  Unparalleled control of neural activity using orthogonal pharmacogenetics.

Authors:  Mikhail G Shapiro; Shawnalea J Frazier; Henry A Lester
Journal:  ACS Chem Neurosci       Date:  2012-06-01       Impact factor: 4.418

9.  Loss of the limbic mineralocorticoid receptor impairs behavioral plasticity.

Authors:  Stefan Berger; David P Wolfer; Oliver Selbach; Heike Alter; Gitta Erdmann; Holger M Reichardt; Aisa N Chepkova; Hans Welzl; Helmut L Haas; Hans-Peter Lipp; Günther Schütz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-20       Impact factor: 11.205

10.  Severe hyperkalemia is rescued by low-potassium diet in renal βENaC-deficient mice.

Authors:  Emilie Boscardin; Romain Perrier; Chloé Sergi; Marc Maillard; Johannes Loffing; Dominique Loffing-Cueni; Robert Koesters; Bernard Claude Rossier; Edith Hummler
Journal:  Pflugers Arch       Date:  2017-05-31       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.